<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04902924</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00546</org_study_id>
    <nct_id>NCT04902924</nct_id>
  </id_info>
  <brief_title>Cold and Warm Water for Performance Recovery</brief_title>
  <official_title>A Randomized Controlled Trial to Evaluate the Effectiveness of Repeated Cold- and Warm Water Immersion on Performance Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Applied Sciences and Arts of Southern Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Applied Sciences and Arts of Southern Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall aim of this study is, to evaluate the effectiveness of repeated cold- and warm&#xD;
      water immersion on performance recovery after muscle damage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants perform a muscle-damage protocol, which comprises 5x20 drop jumps. After the&#xD;
      exercise protocol is finished, the participants will undergo one of three recovery&#xD;
      interventions. Cold-water immersion, Warm-water immersion or the control-intervention. During&#xD;
      the exercise protocol and the recovery intervention following parameters will be assessed:&#xD;
      Blood oxygenation, Muscle oxygenation, heart-rate, skin temperature and core temperature.&#xD;
&#xD;
      Then, performance recovery will be assessed during the following 72 hrs (in a 24 hrs&#xD;
      interval).&#xD;
&#xD;
      At each time-point, following measurements will be conducted: vertical-jump performance,&#xD;
      maximum voluntary isometric contraction of the m.quadriceps femoris muscle, muscle swelling&#xD;
      and delayed-onset of muscle soreness.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study is a randomized controlled trial</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>maximun voluntary isometric contraction (Nm)</measure>
    <time_frame>baseline to 72 hours</time_frame>
    <description>maximun voluntary isometric contraction of the knee extensor muscle will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vertical jump performance (cm)</measure>
    <time_frame>baseline to 72 hours</time_frame>
    <description>maximum vertical jump performance will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>delayed onset of muscle soreness (units)</measure>
    <time_frame>baseline to 72 hours</time_frame>
    <description>delayed onset of muscle soreness will be measured using a 0-10 scale, where 0 indicated no soreness and 10 indicates maximum soreness of the knee extensor muscles</description>
  </primary_outcome>
  <primary_outcome>
    <measure>muscle swelling (mm)</measure>
    <time_frame>baseline to 72 hours</time_frame>
    <description>swelling of the knee extensor muscle will be performed using a ultrasound device.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Creatine-kinase (U/l)</measure>
    <time_frame>baseline to 72 hours</time_frame>
    <description>using a blood sample (6 ml), creatine-kinase will be assessed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood oxygenation (%)</measure>
    <time_frame>through recovery intervention up to 1 hour</time_frame>
    <description>Blood oxygenation will be measured using near-infrared spectroscopy device at the finger</description>
  </primary_outcome>
  <primary_outcome>
    <measure>muscle blood oxygenation (%)</measure>
    <time_frame>through recovery intervention up to 1 hour</time_frame>
    <description>Muscle oxygenation will be measured using near-infrared spectroscopy device at the knee extensor muscle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>skin temperature (째C)</measure>
    <time_frame>through recovery intervention up to 1 hour</time_frame>
    <description>Skin temperature will be measured using a near infrared thermography camera</description>
  </primary_outcome>
  <primary_outcome>
    <measure>core temperature (째C)</measure>
    <time_frame>through recovery intervention up to 1 hour</time_frame>
    <description>core temperature will be measured using temperature pill that will provide real time values from the gastrointestinal region</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Repeated cold-water immersion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm, the participants undergo repeated cold water immersion at 10째C for 2 x 5 min. Between the immersion, a break will be conducted 2.5 min. Participants will be immersed up to the iliac crest</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Repeated warm-water immersion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this arm, the participants undergo repeated warm water immersion at 40째C for 2 x 5 min. Between the immersion, a break will be conducted 2.5 min. Participants will be immersed up to the iliac crestParticipants will be immersed up to the iliac crest.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In this arm, the participants undergo the control intervention which comprises to remain seated for 12.5 min. The participants, that will perform the muscle damaging protocol under hypoxia will also be treated with the control condition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>repeated cold water therapy</intervention_name>
    <description>This information can be found the description of the experimental arm.</description>
    <arm_group_label>Repeated cold-water immersion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>repeated warm water therapy</intervention_name>
    <description>This information can be found the description of the experimental arm.</description>
    <arm_group_label>Repeated warm-water immersion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>This information can be found the description of the experimental arm.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy participants&#xD;
&#xD;
          -  No surgeries&#xD;
&#xD;
          -  No previous injuries&#xD;
&#xD;
          -  Anticonceptiva allowed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute injuries or current pain situations&#xD;
&#xD;
          -  Cryophobia&#xD;
&#xD;
          -  Fear&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Raynaud syndrome&#xD;
&#xD;
          -  Medication intake&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Clijsen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Applied Sciences and Arts of Southern Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ron Clijsen, PhD</last_name>
    <phone>+41813000175</phone>
    <email>ron.clijsen@supsi.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erich Hohenauer, PhD</last_name>
    <phone>+41813000175</phone>
    <email>erich.hohenauer@supsi.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Applied Sciences and Arts of Southern Switzerland</name>
      <address>
        <city>Landquart</city>
        <state>GR</state>
        <zip>7302</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Ron Clijsen, PhD</last_name>
      <phone>+41813000175</phone>
      <email>ron.clijsen@supsi.ch</email>
    </contact>
    <contact_backup>
      <last_name>Erich Hohenauer, PhD</last_name>
      <phone>+41813000175</phone>
      <email>erich.hohenauer@supsi.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Applied Sciences and Arts of Southern Switzerland</investigator_affiliation>
    <investigator_full_name>Ron Clijsen</investigator_full_name>
    <investigator_title>Head of research</investigator_title>
  </responsible_party>
  <keyword>cold water immersion</keyword>
  <keyword>warm water immersion</keyword>
  <keyword>muscle damage</keyword>
  <keyword>recovery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

